
South Africa tightens rules on weight-loss drugs
Semafor semafor.com
This is what was read here when it was published. Tiisetso Motsoeneng no longer carries it in what it publishes now.
Pharmaceutical giants Novo Nordisk and Eli Lilly have sought to curb the pharmacy-made products competing with their blockbuster GLP-1 drugs.
More ways to use this
Open on another device
Scan to open this page. Your saved notes and account access are not included.